1 ring octreotide, studies were performed in 5 acromegalics.

2  was also done on intestinal biopsies of all acromegalics and healthy controls.

3 ta from this study suggest that treatment of acromegalic arthropathy should involve inhibition of ect

4 LBTTs) in 4 groups of 8 individuals: (1) non-acromegalic controls, (2) acromegalics untreated with oc

5  acromegalics untreated with octreotide, (3) acromegalics on long-term octreotide, and (4) patients w

6 , all GH-producing adenomas originating from acromegalic patients demonstrated up-regulation of GHRH-

7 mass and thickness in myocardial biopsies of acromegalic patients, in which IGF-1 is overproduced aft

8 f overt somatotropinomas in Aip+/- mice; the acromegalic phenotype of these mice is surprisingly amel

9 rol gallstones-including those developing in acromegalics treated with octreotide.

10 ific analog also exclusively inhibited GH in acromegalic tumor cells.

11 dividuals: (1) non-acromegalic controls, (2) acromegalics untreated with octreotide, (3) acromegalics

12 uodenum and colon was significantly lower in acromegalics with diabetes as compared to healthy contro